Personalized medicine and inhibition of EGFR signaling in lung cancer

Adi F. Gazdar

doi:10.1056/NEJMe0905763

Personalized medicine and inhibition of EGFR signaling in lung cancer

Adi F. Gazdar

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1018-1020
Number of pages	3
Journal	New England Journal of Medicine
Volume	361
Issue number	10
DOIs	https://doi.org/10.1056/NEJMe0905763
State	Published - Sep 3 2009

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMe0905763

Cite this

@article{2ed32cf0eabd4b5583e2d1f7c063c779,

title = "Personalized medicine and inhibition of EGFR signaling in lung cancer",

author = "Gazdar, {Adi F.}",

year = "2009",

month = sep,

day = "3",

doi = "10.1056/NEJMe0905763",

language = "English (US)",

volume = "361",

pages = "1018--1020",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Personalized medicine and inhibition of EGFR signaling in lung cancer

AU - Gazdar, Adi F.

PY - 2009/9/3

Y1 - 2009/9/3

UR - http://www.scopus.com/inward/record.url?scp=69949126786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949126786&partnerID=8YFLogxK

U2 - 10.1056/NEJMe0905763

DO - 10.1056/NEJMe0905763

M3 - Editorial

C2 - 19692681

AN - SCOPUS:69949126786

SN - 0028-4793

VL - 361

SP - 1018

EP - 1020

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -

Personalized medicine and inhibition of EGFR signaling in lung cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this